GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 295 filers reported holding GUARDANT HEALTH INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,218,000 | -16.0% | 65,000 | -31.6% | 0.34% | -22.5% |
| Q2 2022 | $3,832,000 | -39.1% | 95,000 | 0.0% | 0.44% | -30.0% |
| Q1 2022 | $6,293,000 | -68.6% | 95,000 | -52.5% | 0.62% | -53.4% |
| Q4 2021 | $20,046,000 | -21.8% | 200,000 | -2.4% | 1.33% | -25.9% |
| Q3 2021 | $25,627,000 | +17.9% | 205,000 | +17.1% | 1.80% | +22.0% |
| Q2 2021 | $21,733,000 | -36.7% | 175,000 | -22.2% | 1.48% | -38.4% |
| Q1 2021 | $34,346,000 | +56.8% | 225,000 | +32.4% | 2.40% | +33.9% |
| Q4 2020 | $21,910,000 | -18.3% | 170,000 | -29.2% | 1.79% | -25.0% |
| Q3 2020 | $26,827,000 | +78.7% | 240,000 | +29.7% | 2.38% | +47.1% |
| Q2 2020 | $15,009,000 | +23.2% | 185,000 | +5.7% | 1.62% | -5.0% |
| Q1 2020 | $12,180,000 | +0.4% | 175,000 | +12.7% | 1.71% | +28.3% |
| Q4 2019 | $12,133,000 | +443.1% | 155,268 | +343.6% | 1.33% | +375.0% |
| Q3 2019 | $2,234,000 | – | 35,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |